Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure - A clinical review

被引：24

作者：

de Virginy, David R. Buvat ^{[1
]}

机构：

[1] St Johns Clin, Dept Internal Med, Rolla, MO 65401 USA

来源：

HEART FAILURE REVIEWS | 2006年 / 11卷 / 04期

关键词：

heart failure; biomarkers; prognosis; neurohormones; myocardial remodeling;

D O I：

10.1007/s10741-006-0234-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Over the last two decades, the pathophysiology and biomolecular basis of heart failure syndrome has reached sound and more comprehensive understanding. This knowledge has allowed expert researchers and clinicians to explore an entirely new spectrum of potential biochemical markers derived from different cellular and signaling pathways that lead to myocardial hypertrophy, chronic damage of the myocyte, apoptosis, and, ultimately, myocardial remodeling. Indeed, the link between myocardial remodeling and adverse outcomes, as well as the recognition of the myocardial interstitium as a multifunctional dynamic entity strongly influenced by systemic neurohormonal and inflammatory activation, has provided a solid ground for research of biomarkers that might correlate with severity and prognostication in chronic heart failure. This paper reviews and summarize recent literature on some of the most interesting circulating biomarkers with potential use for the stratification of patients with chronic heart failure.

引用

页码：333 / 344

页数：12

共 128 条

[1]

AH W, 2003, AM J CARDIOL, V92, P628

[2] Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement - Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study [J].

Anwaruddin, S ;

Lloyd-Jones, DM ;

Baggish, A ;

Chen, A ;

Krauser, D ;

Tung, R ;

Chae, C ;

Januzzi, JL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) :91-97

[3] Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure [J].

Arimoto, T ;

Takeishi, Y ;

Niizeki, T ;

Takabatake, N ;

Okuyama, H ;

Fukui, A ;

Tachibana, H ;

Nozaki, N ;

Hirono, O ;

Tsunoda, Y ;

Miyashita, T ;

Shishido, T ;

Takahashi, H ;

Koyama, Y ;

Kubota, I .

JOURNAL OF CARDIAC FAILURE, 2005, 11 (08) :595-601

[4] Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure [J].

Arimoto, T ;

Takeishi, Y ;

Shiga, R ;

Fukui, A ;

Tachibana, H ;

Nozaki, N ;

Hirono, O ;

Nitobe, J ;

Miyamoto, T ;

Hoit, BD ;

Kubota, I .

JOURNAL OF CARDIAC FAILURE, 2005, 11 (01) :56-60

[5] Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy [J].

Aukrust, P ;

Ueland, T ;

Lien, E ;

Bendtzen, K ;

Müller, F ;

Andreassen, AK ;

Nordoy, I ;

Aass, H ;

Espevik, T ;

Simonsen, S ;

Froland, SS ;

Gullestad, L .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (03) :376-382

[6] Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction [J].

Balzan, S ;

Neglia, D ;

Ghione, S ;

D'Urso, G ;

Baldacchino, MC ;

Montali, U ;

L'Abbate, A .

EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (02) :165-171

[7] Neurohormonal activation is associated with increased levels of plasma matrix metal loproteinase-2 in human heart failure [J].

Banfi, C ;

Cavalca, V ;

Veglia, F ;

Brioschi, M ;

Barcella, S ;

Mussoni, L ;

Boccotti, L ;

Tremoli, E ;

Biglioli, P ;

Agostoni, P .

EUROPEAN HEART JOURNAL, 2005, 26 (05) :481-488

[8] COMPARATIVE NEUROHORMONAL RESPONSES IN PATIENTS WITH PRESERVED AND IMPAIRED LEFT-VENTRICULAR EJECTION FRACTION - RESULTS OF THE STUDIES OF LEFT-VENTRICULAR DYSFUNCTION (SOLVD) REGISTRY [J].

BENEDICT, CR ;

WEINER, DH ;

JOHNSTONE, DE ;

BOURASSA, MG ;

GHALI, JK ;

NICKLAS, J ;

KIRLIN, P ;

GREENBERG, B ;

QUINONES, MA ;

YUSUF, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) :A146-A153

[9] Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease [J].

Blankenberg, S ;

Rupprecht, HJ ;

Poirier, O ;

Bickel, C ;

Smieja, M ;

Hafner, G ;

Meyer, J ;

Cambien, F ;

Tiret, L .

CIRCULATION, 2003, 107 (12) :1579-1585

[10] von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis [J].

Blann, AD ;

McCollum, CN .

BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (06) :375-380

← 1 2 3 4 5 6 7 8 9 10 →